45
Items sold in last 3 hours
oncoplus capsule 30 cap free shipping nisarg health care best buy
₹630.00 inc. Tax
Free Shipping on orders above ₹1000 for this Product!
Highlights
oncoplus capsule 30 cap free shipping nisarg health care
192
People watching this product now!
Worldwide shipping offered
4972 in stock
ⓘ
Free Shipping is only applicable when this specific product is the sole item in your cart.
4972 in stock
ⓘ
Free Shipping is only applicable when this specific product is the sole item in your cart.
About Product
Description
Description
oncoplus capsule 30 cap free shipping nisarg health care is an excellent cellular support product, made using time-tested and natural ayurvedic herbs.
It was originally created to support the quality of life for people receiving chemotherapy or radiation, although the breadth of this formula makes it ideal for anyone needing cellular support.
Ideal for : Restoring mental alertness and energy and supporting healthy immune function.
The best of herbs to help you conquer cancer
Cancer is one of the most varied, complex, and widespread diseases in the world today.
Cancer attacks the human immune system, weakening the mental, physical as well as emotional defenses.
Our product is an excellent cellular support product, made using time-tested and natural Ayurvedic herbs.
It was originally created to support the quality of life for people receiving chemotherapy or radiation, although the breadth of this formula makes it ideal for anyone needing cellular support.
Additional information
Additional information
| Weight | 30.00000000 g |
|---|---|
| Brand |
Reviews (0)
Reviews (0)
You must be logged in to post a review.
Best Before
Expires in between 6 Months to 2 Years from Today
our courier partner
Customer review
Reviews
Clear filtersThere are no reviews yet.
You must be logged in to post a review.
Reviews (0)
Reviews (0)
Reviews
Clear filtersThere are no reviews yet.
You must be logged in to post a review.
Related Products
.png.webp)
.jpg.webp)
Reviews
Clear filtersThere are no reviews yet.